Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRH for Cancer-Related Fatigue
NCT00790296Phase 2Terminated
- Sponsor
- UConn Health
- Start
- Dec 2006
- Primary completion
- Feb 2010
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of thyrotropin-releasing hormone in cancer-related fatigue (CRF), sponsored by UConn Health. Started Dec 2006; status: terminated.
02
Drugs
thyrotropin-releasing hormone
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT00790296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00790296.